Institutional Ownership Enanta Pharmaceuticals Inc (ENTA)
This table provides information about the institutional ownership of Enanta Pharmaceuticals Inc (ENTA). We have compiled data on the 128 institutions that hold shares in the stock, with a total of 19.4 Million shares, which have been reported (via 13F filing form) to have a value of $234 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Tang Capital Management LLC
San Diego, CA |
Nov 14, 2025 Q3 2025 |
126,655
shares
|
$1.53 Million
0.07% of portfolio
|
Q3 2024
Reduced 57.78%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2025 Q3 2025 |
125,100
shares
|
$1.51 Million
0.0% of portfolio
|
Q3 2025
Reduced 6.36%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 26, 2025 Q3 2025 |
123,817
shares
|
$1.49 Million
0.0% of portfolio
|
Q3 2025
Reduced 7.74%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2025 Q3 2025 |
117,304
shares
|
$1.41 Million
0.0% of portfolio
|
Q3 2025
Added 59.04%
|
|
|
Pdt Partners, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
86,022
shares
|
$1.04 Million
0.07% of portfolio
|
Q3 2025
Reduced 0.84%
|
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Nov 13, 2025 Q3 2025 |
77,506
shares
|
$934,722
0.0% of portfolio
|
Q3 2025
Added 423.83%
|
|
|
Stem Point Capital LP
New York, NY |
Nov 14, 2025 Q3 2025 |
75,194
shares
|
$906,839
0.18% of portfolio
|
Q3 2025
New holding
|
|
|
Sei Investments CO
Oaks, PA |
Nov 13, 2025 Q3 2025 |
73,853
shares
|
$890,667
0.0% of portfolio
|
Q1 2025
Added 1.46%
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
60,722
shares
|
$732,307
0.0% of portfolio
|
Q3 2025
Reduced 22.6%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 13, 2025 Q3 2025 |
59,698
shares
|
$719,957
0.0% of portfolio
|
Q3 2025
Reduced 5.07%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
55,607
shares
|
$670,620
0.0% of portfolio
|
Q2 2024
Reduced 37.79%
|
|
|
Assenagon Asset Management S.A.
|
Oct 07, 2025 Q3 2025 |
54,257
shares
|
$654,339
0.0% of portfolio
|
Q3 2025
Reduced 49.0%
|
|
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
Nov 14, 2025 Q3 2025 |
50,434
shares
|
$608,234
0.02% of portfolio
|
Q2 2025
Reduced 46.0%
|
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
Nov 14, 2025 Q3 2025 |
49,983
shares
|
$602,794
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
American Century Companies Inc
Kansas City, MO |
Nov 12, 2025 Q3 2025 |
48,571
shares
|
$585,766
0.0% of portfolio
|
Q3 2025
Added 19.1%
|
|
|
Skopos Labs, Inc.
Riverhead, NY |
Nov 14, 2025 Q3 2025 |
43,153
shares
|
$520,425
0.06% of portfolio
|
Q3 2025
Added 1.5%
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
41,621
shares
|
$501,949
0.0% of portfolio
|
Q3 2025
Reduced 13.09%
|
|
|
Man Group PLC
London, X0 |
Nov 14, 2025 Q3 2025 |
40,156
shares
|
$484,281
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Ieq Capital, LLC
|
Nov 14, 2025 Q3 2025 |
37,686
shares
|
$454,493
0.0% of portfolio
|
Q3 2025
Reduced 6.6%
|
|
|
Graham Capital Management, L.P.
Rowayton, CT |
Nov 14, 2025 Q3 2025 |
37,323
shares
|
$450,115
0.01% of portfolio
|
Q3 2025
Added 99.27%
|
|
|
Quantinno Capital Management LP
New York, NY |
Nov 14, 2025 Q3 2025 |
37,126
shares
|
$447,739
0.0% of portfolio
|
Q3 2025
Added 200.83%
|
|
|
Phar Vision Advisers, LLC
Boca Raton, FL |
Nov 14, 2025 Q3 2025 |
35,846
shares
|
$432,302
0.24% of portfolio
|
Q3 2025
New holding
|
|
|
Thrivent Financial For Lutherans
Minneapolis, MN |
Nov 04, 2025 Q3 2025 |
34,041
shares
|
$410,534
0.0% of portfolio
|
Q3 2025
Reduced 60.34%
|
|
|
Bank Of Montreal
Toronto, A6 |
Nov 13, 2025 Q3 2025 |
33,868
shares
|
$408,448
0.0% of portfolio
|
Q2 2025
Added 32.8%
|
|
|
Alliancebernstein L.P.
New York, NY |
Nov 14, 2025 Q3 2025 |
33,740
shares
|
$406,904
0.0% of portfolio
|
Q2 2025
Added 12.69%
|
|